pamidronate has been researched along with indomethacin in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 2 (13.33) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Heath, DA; Mundy, GR; Wilkinson, R | 1 |
Fischer, JT; Peters, U; Schürer, CC | 1 |
Algan, SA; Horowitz, SM; Purdon, MA | 1 |
Berman, SK; Blank, MA; Ems, BL; Gibson, GW; Myers, WR; Phipps, RJ; Smith, PN | 1 |
Blank, MA; Dierckman, TA; Gibson, GW; Myers, WR; Phipps, RJ; Smith, PN | 1 |
Blank, MA; Gibson, GW; Lichtenberger, LM; Romero, JJ | 1 |
Banerjee, S; Phaujdar, S; Santra, G; Sarkar, RN; Siddhanta, S | 1 |
1 review(s) available for pamidronate and indomethacin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pamidronate and indomethacin
Article | Year |
---|---|
Comparative study of available medical therapy for hypercalcemia of malignancy.
Topics: Administration, Oral; Adult; Aged; Calcium; Clinical Trials as Topic; Diphosphonates; Etidronic Acid; Female; Glucocorticoids; Humans; Hypercalcemia; Hyperparathyroidism; Indomethacin; Male; Middle Aged; Neoplasms; Pamidronate; Phosphates; Plicamycin; Random Allocation; Time Factors | 1983 |
13 other study(ies) available for pamidronate and indomethacin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Therapeutic possibilities in paraneoplastic hypercalcemia].
Topics: Adrenal Cortex Hormones; Adult; Aged; Calcitonin; Diphosphonates; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Indomethacin; Male; Middle Aged; Pamidronate; Paraneoplastic Syndromes; Plicamycin | 1981 |
Pharmacologic inhibition of particulate-induced bone resorption.
Topics: Analysis of Variance; Animals; Animals, Newborn; Bone Cements; Bone Resorption; Calcitonin; Calcium; Cell Line; Coculture Techniques; Dinoprostone; Diphosphonates; Female; Indomethacin; Interleukin-1; Kinetics; Macrophages; Pamidronate; Pregnancy; Rats; Skull; Tumor Necrosis Factor-alpha | 1996 |
Nonclinical model for assessing gastric effects of bisphosphonates.
Topics: Alendronate; Animals; Chelating Agents; Diphosphonates; Edetic Acid; Egtazic Acid; Etidronic Acid; Indomethacin; Male; Pamidronate; Rats; Rats, Sprague-Dawley; Risedronic Acid; Stomach | 1997 |
Gastric damage in the rat with nitrogen-containing bisphosphonates depends on pH.
Topics: Administration, Oral; Alendronate; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium Channel Blockers; Diphosphonates; Etidronic Acid; Hydrogen-Ion Concentration; Indomethacin; Male; Pamidronate; Rats; Rats, Sprague-Dawley; Risedronic Acid; Stomach; Structure-Activity Relationship | 2000 |
Effect of bisphosphonates on surface hydrophobicity and phosphatidylcholine concentration of rodent gastric mucosa.
Topics: Alendronate; Animals; Anti-Inflammatory Agents; Diphosphonates; Etidronic Acid; Gastric Mucosa; Indomethacin; Male; Pamidronate; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Risedronic Acid; Surface Properties | 2000 |
Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood Sedimentation; C-Reactive Protein; Cyclooxygenase 2 Inhibitors; Diclofenac; Diphosphonates; Etodolac; Female; Health Status Indicators; Humans; Indomethacin; Male; Pamidronate; Prospective Studies; Spondylitis, Ankylosing; Treatment Failure; Tumor Necrosis Factor-alpha; Young Adult | 2010 |